Apella Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8.05M Buy
6,774
+2,498
+58% +$2.95M 0.1% 142
2026
Q2
$5.28M Buy
4,276
+139
+3% +$142K 0.07% 160
2026
Q1
$3.84M Buy
4,137
+963
+30% +$976K 0.06% 187
2025
Q4
$3.41M Buy
3,174
+1,083
+52% +$1.04M 0.07% 160
2025
Q3
$1.71M Buy
2,091
+260
+14% +$193K 0.04% 193
2025
Q2
$1.42M Buy
1,831
+82
+5% +$63.7K 0.04% 182
2025
Q1
$1.32M Buy
1,749
+151
+9% +$126K 0.05% 165
2024
Q4
$1.23M Sell
1,598
-6
-0.4% -$4.97K 0.05% 150
2024
Q3
$1.43M Buy
1,604
+16
+1% +$14.4K 0.06% 126
2024
Q2
$1.48M Sell
1,588
-22
-1% -$17.6K 0.07% 124
2024
Q1
$1.22M Buy
1,610
+6
+0.4% +$4.27K 0.06% 131
2023
Q4
$986K Sell
1,604
-11
-0.7% -$6.42K 0.05% 136
2023
Q3
$867K Buy
1,615
+804
+99% +$414K 0.06% 127
2023
Q2
$380K Buy
+811
New +$340K 0.03% 187
2022
Q4
$341K Buy
+932
New +$330K 0.03% 180

Other funds holding LLY

Apella Capital's LLY Position: Q3 2026 in Review

Apella Capital increased its Eli Lilly (LLY) stake by 58% in Q3 2026, buying an estimated $2.95M and bringing the position to 6,774 shares worth $8.05M. The position accounts for 0.1% of the portfolio, ranked #142.

Apella Capital first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 1,387 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Apella Capital held 6,774 shares of Eli Lilly worth $8.05M as of Q3 2026.
  • Apella Capital bought 2,498 Eli Lilly shares in Q3 2026, an estimated $2.95M.
  • Eli Lilly made up 0.1% of Apella Capital's portfolio in Q3 2026, its #142 holding.
  • Apella Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 1,387 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Apella Capital's 13F filing for Q3 2026, filed 8 Oct 2026.